Craniofrontonasal syndrome (CFNS)

What is Craniofrontonasal Syndrome?

Craniofrontonasal syndrome is a rare genetic condition with just 115 cases reported worldwide to date.

The main symptom of this rare disease is the premature fusing together of the bones of the skull. This cause the unique facial features associated with the syndrome.

Syndrome Synonyms:
CFND Craniofrontonasal Dysostosis; Craniofrontonasal Dysplasia; Cfnd

What gene change causes Craniofrontonasal Syndrome?

Le syndrome est une maladie génétique récessive liée à l'X. Elle affecte les femmes plus fréquemment et plus sévèrement que les hommes. La plupart des hommes ne sont pas diagnostiqués avec la maladie. En raison de la nature de l'héritage génétique de ce trouble lié à l'X, les pères ne peuvent pas le transmettre à leurs fils.

Les les syndromes hérités d'un schéma récessif lié à l'X n'affectent généralement que les hommes. Les mâles n'ont qu'un seul chromosome X, et donc une copie d'une mutation génique sur celui-ci provoque le syndrome. Les femelles, avec deux chromosomes X, dont un seul sera muté, ne seront probablement pas affectées.

what are the main symptoms of Craniofrontonasal Syndrome?

Premature closure of the bones of the skull, as it is developing, causes most of the unique facial and head characteristics of the syndrome.

These include facial asymmetry, a slit in the top of the nose, a broad nose, widely spaced eyes, eyes that look in different directions, a webbed neck and sloping shoulders.

Sometimes there is an impact on brain development and mild intellectual disability may be a potential secondary symptom.

Possible clinical traits/features:
Muscular hypotonia, Hemihypotrophy of lower limb, Low posterior hairline, Intellectual disability, Midline defect of the nose, Pectus excavatum, Joint laxity, Joint hypermobility, Toe syndactyly, Plagiocephaly, Hand polydactyly, Nystagmus, Sensorineural hearing impairment, Short neck, Thickened nuchal skin fold, Shawl scrotum, Widow's peak, Cleft palate, Oral cleft, Congenital pseudoarthrosis of the clavicle, Aplasia/Hypoplasia of the corpus callosum, Aplasia/Hypoplasia of the nipples, Axillary pterygium, Broad hallux, Bifid nasal tip, Brachycephaly, Wide nasal bridge, Abnormality of the clavicle, Abnormal fingernail morphology, Abnormal toenail morphology, Abnormal palate morphology, Abnormality of the dentition, Abnormality of the shoulder, Abnormality of the rib cage, Hypertelorism, High anterior hairline, Hypospadias, Hypoplasia of the corpus callosum, Fragile nails, Cognitive impairment, Global developmental delay, Short stature, Hypoplastic nasal tip, Craniosynostosis, Cryptorchidism, Coronal craniosyno

How does someone get tested for Craniofrontonasal Syndrome?

Le dépistage initial du syndrome craniofrontonasal peut commencer par un dépistage par analyse faciale, via le FDNA Telehealth plate-forme de télégénétique, qui peut identifier les marqueurs clés du syndrome et souligner le besoin de tests supplémentaires. Une consultation avec un conseiller en génétique puis un généticien suivra.

Sur la base de cette consultation clinique avec un généticien, les différentes options de tests génétiques seront partagées et le consentement sera recherché pour d'autres tests.

Medical information on Craniofrontonasal Syndrome

This condition combines frontonasal dysplasia with craniosynostosis. The clinical features are severe hypertelorism, a broad bifid nose, frontal bossing (which might be asymmetrical), a low posterior hairline with an anterior widow's peak, and occasionally a cleft lip and palate.

Radiographs of the skull show premature coronal synostosis. Most children have a normal intelligence, although mild delay has been reported.

If the palate is intact, it is often high with widely spaced teeth and mal-eruption. Neck webbing, rounded shoulders, abnormal clavicles and raised scapulae are all features. In the limbs there is often longitudinal splitting of the nails, occasionally skin syndactyly, and the fingers and toes might be deviated distally or, occasionally, hypoplastic.

McPherson et al., (1991), in an abstract, reported a female with a del(X)(p22.2)->pter with features of the condition.

Note that Ward et al., (1993) reported a female infant with a de novo reciprocal translocation (46,XX,t(1;18)(p31;q11)) with preaxial polysyndactyly, craniosynostosis and partial agenesis of the corpus callosum.

Mulvihill et al., (1993) reported a family with features of craniofrontonasal dysplasia. An interstitial deletion of 10p with breakpoints at p11.21 and p11.23 was found in three affected family members who were tested.

Feldman et al., (1997) mapped the gene to Xp22 and noted the association with cleft lip and palate in four out of 12 affected males (one with a pseudo cleft). The main manifestation in males was otherwise just hypertelorism. Pulleyn et al., (1999) provide further evidence for linkage to Xp12-Xp22 region. The gene eprin-B1 (EFNB1) has now been identified (Wieland et al., 2004, Twigg et al., 2004). It is a marker of tissue boundary formation.

Saavedra et al., (1996) reported 41 cases from Mexico, of whom 35 were female and six were male. Most cases were sporadic, but there were seven familial cases. Unusual manifestations that were noted included thick wiry and curly hair with irregularities in disposition of keratin filaments on scanning EM, anterior cranium bifidum, axillary pterygia, unilateral breast hypoplasia, and asymmetric lower limbs.

Kapusta et al., (1992) reported seven classical cases of the condition. One case was male. In two fathers of female cases, there were mild features of the condition. An unaffected father, with a mutation, and his two severely affected daughters were reported by Ozyilmaz et al., (2015). Natarajan et al., (1993) reported the syndrome in two male sibs with normal parents.

In a series of patients (van den Elzen et al., 2014), 91% had a bifid nose, 91% a columella indentation and 90% had a low implantation of the breasts (one unconvincing picture shown). Cantrell et al., (1994), Reardon et al., (1990) and Webster and Deming (1950) reported probable cases with unilateral absence of the pectoralis major muscle (ie. features of Poland anomaly). Erdogan et al., (1996) also reported a case with this association. There was polythelia of the left breast.

There are more females reported than males. Males may be less severely affected than females, and Devriendt et al., (1995) reported this phenomenon in a mother and son. Grutzner et al., (1988) suggested that inheritance is X-linked dominant but could not explain why females were more severely affected than males.

Twigg et al., (2006), have addressed the question as to why there are so few affected males. By using the gene EFNB1 (see below) they showed that of 17 germline mutations, 15 arose from the father, hence the relative scarcity in males. Postzygotic mutations (six out of 53), which would be expected to occur twice as frequently in female embryos and may be more likely to manifest because of X inactivation, also contributed to the excess of females.

Congenital diaphragmatic hernia can be part of the clinical picture (Hogue et al., 2010). Diaphragmatic hernia may be a rare association (Brooks et al., 2002, McGaughran et al., 2002, and Vasudevan et al., 2006).

Two females with de novo deletions of EFNB1 had in addition deletions of OPHN1 and PJA1 (Wieland et al., 2007). A third with mental slowness had only the additional deletion of OPHNI. The authors state that there might be implications for the male offspring in terms of intellectual disability and anhidrotic ectodermal dysplasia.

Six males were investigated by Twigg et al., (2013) who found that males mosaic for the EFNB1 mutation are more severely affected than hemizygous males.

Inoue et al. (2017) reported a family with three individuals with this syndrome and bilateral cleft lip and palate.

* This information is courtesy of the L M D.
If you find a mistake or would like to contribute additional information, please email us at: [email protected]

Soyez plus rapide et plus précis Diagnóstico Genético!

Plus de 250,000 patients analysés avec succès!
N'attendez pas des années pour un diagnostic. Agissez maintenant et gagnez un temps précieux.

Commencer ici!

"Notre chemin vers un diagnostic de maladie rare a été un voyage de 5 ans que je ne peux décrire que comme une tentative de faire un road trip sans carte. Nous ne connaissions pas notre point de départ. Nous ne connaissions pas notre destination. Maintenant nous avons de l'espoir. "

Image

Paula et Bobby
Parents de Lillie

Qu'est-ce que la FDNA Telehealth?

FDNA Telehealth est une entreprise de santé numérique de premier plan qui offre un accès plus rapide à une Analyse Génétique précise.

Dotée d'une technologie hospitalière recommandée par les plus grands généticiens, notre plateforme unique met les patients en contact avec des Experts En Génétique pour répondre à leurs questions les plus urgentes et clarifier toute préoccupation qu'ils pourraient avoir concernant leurs Symptômes.

Avantages de la FDNA Telehealth

Icône FDNA

Credibility

Notre plateforme est actuellement utilisée par plus de 70% des généticiens et a été utilisée pour diagnostiquer plus de 250,000 patients dans le monde.

Icône FDNA

Accessibilité

FDNA Telehealth fournit une analyse faciale et un dépistage en quelques minutes, suivi d'un accès rapide aux conseillers en génétique et aux généticiens.

Icône FDNA

Facilité d'utilisation

Notre processus transparent commence par un diagnostic initial en ligne par un conseiller en génétique et s'ensuit par des consultations avec des généticiens et des tests génétiques.

Icône FDNA

Précision et précision

Capacités et technologies avancées d'intelligence artificielle (IA) avec un taux de précision de 90% pour une meilleure précision analyse génétique.

Icône FDNA

La valeur pour
De l'argent

Accès plus rapide aux conseillers en génétique, aux généticiens, aux tests génétiques et au diagnostic. En moins de 24 heures si nécessaire. Économisez du temps et de l'argent.

Icône FDNA

Confidentialité et sécurité

Nous garantissons la meilleure protection de toutes les images et informations des patients. Vos données sont toujours sûres, sécurisées et cryptées.

La FDNA Telehealth peut vous rapprocher d'un diagnostic.
Planifiez une réunion de conseil ginitique en ligne dans les 72 heures!

EspañolDeutschPortuguêsFrançaisEnglish